全文获取类型
收费全文 | 22151篇 |
免费 | 1622篇 |
国内免费 | 447篇 |
专业分类
耳鼻咽喉 | 116篇 |
儿科学 | 594篇 |
妇产科学 | 320篇 |
基础医学 | 1714篇 |
口腔科学 | 617篇 |
临床医学 | 1833篇 |
内科学 | 2741篇 |
皮肤病学 | 251篇 |
神经病学 | 1539篇 |
特种医学 | 1591篇 |
外科学 | 1961篇 |
综合类 | 1849篇 |
现状与发展 | 1篇 |
一般理论 | 2篇 |
预防医学 | 3598篇 |
眼科学 | 232篇 |
药学 | 2630篇 |
3篇 | |
中国医学 | 1283篇 |
肿瘤学 | 1345篇 |
出版年
2024年 | 52篇 |
2023年 | 334篇 |
2022年 | 442篇 |
2021年 | 669篇 |
2020年 | 745篇 |
2019年 | 721篇 |
2018年 | 655篇 |
2017年 | 688篇 |
2016年 | 749篇 |
2015年 | 659篇 |
2014年 | 1340篇 |
2013年 | 1566篇 |
2012年 | 1330篇 |
2011年 | 1453篇 |
2010年 | 1052篇 |
2009年 | 1061篇 |
2008年 | 1049篇 |
2007年 | 1140篇 |
2006年 | 952篇 |
2005年 | 950篇 |
2004年 | 835篇 |
2003年 | 782篇 |
2002年 | 588篇 |
2001年 | 490篇 |
2000年 | 385篇 |
1999年 | 351篇 |
1998年 | 322篇 |
1997年 | 252篇 |
1996年 | 212篇 |
1995年 | 246篇 |
1994年 | 238篇 |
1993年 | 205篇 |
1992年 | 223篇 |
1991年 | 187篇 |
1990年 | 113篇 |
1989年 | 114篇 |
1988年 | 123篇 |
1987年 | 93篇 |
1986年 | 83篇 |
1985年 | 130篇 |
1984年 | 94篇 |
1983年 | 76篇 |
1982年 | 77篇 |
1981年 | 67篇 |
1980年 | 64篇 |
1979年 | 46篇 |
1978年 | 54篇 |
1977年 | 47篇 |
1976年 | 28篇 |
1974年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
《Revista de gastroenterologia de Mexico》2022,87(1):52-58
IntroductionThe sofosbuvir-velpatasvir (SOF/VEL) combination is a direct-acting antiviral therapy that is authorized and available in Mexico, making the performance of a real-world multicenter study that evaluates the sustained virologic response at 12 weeks post-treatment a relevant undertaking.MethodsA retrospective review of the case records of 241 patients seen at 20 hospitals in Mexico was conducted to assess hepatitis C treatment with the SOF/VEL combination (n = 231) and the sofosbuvir/velpatasvir/ribavirin (SOF/VEL/RBV) combination (n = 10). The primary efficacy endpoint was the percentage of patients that achieved SVR at 12 weeks after the end of treatment.ResultsOverall SVR was 98.8% (95% CI 97.35-100%). Only three patients did not achieve SVR, two of whom had cirrhosis and a history of previous treatment with peg-IFN. Of the subgroups analyzed, all the patients with HIV coinfection, three patients with genotype 3, and the patients treated with the SOF/VEL/RBV combination achieved SVR. The subgroups with the lower success rates were patients that were treatment-experienced (96.8%) and patients with F1 fibrosis (95.5%). The most frequent adverse events were fatigue, headache, and insomnia. No serious adverse events were reported.ConclusionTreatments with SOF/VEL and SOF/VEL/RBV were highly safe and effective, results coinciding with those of other international real-world studies. 相似文献
2.
3.
《Revue d'épidémiologie et de santé publique》2020,68(2):109-115
BackgroundDuring their training, students in osteopathy regularly undergo spinal manipulation exercises. This exposes the students’ spine to unskilled gestures performed by their colleagues learning spinal manipulation. Discomfort, muscle soreness or moderate pain following spinal manipulations lasting two or three days are commonly reported. In addition, some students may have ongoing spinal musculoskeletal disease (SMSD) during their studies. The purpose of this study was to evaluate the prevalence of SMSDs and their maximum intensity in a population of osteopathy students and to determine whether individual differences exist.MethodAn exploratory cross-sectional study took place over three years. Data were collected by means of a self-administrated standardised questionnaire screening for MSD: the Nordic questionnaire.ResultsThere were 733 exploitable questionnaires, giving an average response rate of 91.5%. Average prevalence of SMSD was 98.4% during the last 12 months. Average maximum intensity perceived was 6/10 and 45% of students experienced an intense SMSD (scored between 7 and 10/10). Variation of the maximum intensity of SMSD between “before osteopathy studies” and “the last 12 months” was 1.2/10. This variation was influenced by the number of days students were manipulated during a week (p < 0.0001). On average, students underwent manipulation three days a week.ConclusionThis study confirms the important prevalence of SMSD among osteopathy students. This result led us to carry out a qualitative study for exploring students’ conceptions in health and spinal manipulative practices. 相似文献
4.
5.
6.
《Gaceta sanitaria / S.E.S.P.A.S》2022,36(4):376-379
ObjectiveTo estimate the prospective relationships between exposure to psychosocial risks dimensions included in the COPSOQ-Istas21 and the deterioration of general and mental health and sleep problems among workers residing in Spain.MethodCohort whose baseline corresponds to the 2016 Psychosocial Risks Survey with a new measurement after one year.ResultsSocial capital and interpersonal relations and leadership dimensions, as well as work?life conflict, were related to all health variables. Dimensions of work organization and job contents did it especially with the mental health, the quantitative demands with the general health and the emotional ones with the mental health. The dimensions related to job insecurity did not show relationships with health.ConclusionsThe results obtained reinforce the role of the COPSOQ-Istas21 as a useful instrument for the evaluation and prevention of psychosocial risks at work. 相似文献
7.
目的对中国精神分裂症患者采取家庭干预的研究文献进行综合回顾和系统评价, 比较不同条件下家庭干预效果的差异。方法在中国知网、维普、万方、中国生物医学文献数据库四大中文数据库及OVID Medline、Science Direct、Web of Science、EBSCO四大英文数据库中, 检索各数据库建库至2015年1月为止使用社会功能缺陷筛选量表(SDSS)、简明精神病(科)量表(BPRS)、阳性与阴性症状量表(PANSS)研究中国精神分裂症患者家庭干预效果的文献, 以标准化加权均数差( SMD)作为效应量, 采用meta分析比较不同干预时间、不同干预类型、对不同病程和不同严重程度的精神分裂症患者的家庭干预效果差异。 结果共纳入57篇符合标准的文献。SDSS、PANSS分析结果显示:① 干预时间越长干预效果越好( P < 0.0001、 P=0.0025);② 单独家庭干预比多个家庭合并单独家庭干预的效果更明显( P < 0.0001、 P=0.0131);③ 干预对于病情较重患者效果较好( P < 0.0001、 P=0.0280)。SDSS量表还显示家庭干预对于病程短的患者效果更好( P < 0.0001)。 结论家庭干预更适合病程较短的精神分裂症患者, 干预应实施较长时间; 单独家庭干预更有利于患者阴性症状的改善和社会功能的康复, 且对于病情较轻患者的阴性症状改善效果更好。 相似文献
8.
骨碎补是历代临床常用中药,具有疗伤止痛、补肾强骨、消风祛斑等功效。其主要含黄酮、苯丙素、三萜、酚酸及其苷等类化学成分,现代研究表明骨碎补具有抗骨质疏松、促进骨折愈合、促软骨再生、护牙健齿、保护肾功能、抗炎、防治中毒性耳聋、降血脂等多种生物活性,开发前景广阔。本文对近年来骨碎补的化学成分、药理作用及临床应用研究进行综述,以期为骨碎补的进一步深入系统的研究和开发利用提供依据。 相似文献
9.
安息香为安息香科白花树Styrax tonkinensis (Pierre) Craib ex Hart.的干燥树脂,主要化学成分为香脂酸类和三萜类物质,及少数木脂素类物质,其中香脂酸类化合物是其主要活性成分。安息香主要药理活性有抗炎解热、抗肿瘤、血脑屏障保护等。本文对安息香药材的化学成分和药理作用进行了综述,并从多角度分析预测了安息香可能的质量标志物,为安息香药材的质量控制、合理开发与利用提供参考。 相似文献
10.